AMBROSHA JORDAN: Open Payments
NPI 1700027307 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 62 payments from 14 companies in 2025. Trend: 2023 $1,188 · 2024 $1,818 · 2025 $1,682
Food & beverage: $1,682
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $404 |
| Novo Nordisk Inc | 6 | $246 |
| ABBVIE INC. | 8 | $235 |
| PFIZER INC. | 8 | $230 |
| Otsuka America Pharmaceutical, Inc. | 12 | $206 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $135 |
| Astellas Pharma US Inc | 2 | $49 |
| SCILEX PHARMACEUTICALS INC. | 2 | $44 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
| Amgen Inc. | 1 | $23 |
Products named: AIRSUPRA, REXULTI, QULIPTA, Wegovy, Kerendia, ZAVZPRET, Ozempic, BREZTRI.
Industry payments across NC — which companies pay providers there.
